Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Myfortic 180 mg gastro-resistant tablets

Active Ingredient:
mycophenolic acid as mycophenolate sodium
Company:  
Novartis Pharmaceuticals UK Ltd See contact details
ATC code: 
L04AA06
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Live Chat HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Myfortic (Mycophenolic acid) - Guide for Healthcare Providers - Risk of teratogenicity

{healthcare_pro_orange} For Healthcare Professionals
This guide has been designed to highlight the risks associated with exposure to mycophenolate during pregnancy, as well as the measures that should be taken to mitigate them.
{pdf_link}

Myfortic (mycophenolic acid) - Guide for Patients - Information about the risks to the unborn baby

This guide is about the risks of mycophenolate for the unborn baby, and the ways to reduce these risks.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Novartis Pharmaceuticals UK Ltd
Company image
Address
2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ
Telephone
+44 (0)1276 692 255
Medical Information Direct Line
+44 (0)1276 698 370
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)845 741 9442
E-mail
[email protected]